| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,796 |
14,831 |
$3.68M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,980 |
16,175 |
$3.03M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,030 |
1,816 |
$592K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,063 |
1,013 |
$391K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,521 |
11,706 |
$341K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,148 |
3,940 |
$332K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,254 |
2,041 |
$258K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,943 |
6,568 |
$222K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,623 |
5,398 |
$210K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,261 |
966 |
$194K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,250 |
1,982 |
$152K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,077 |
980 |
$152K |
| 80053 |
Comprehensive metabolic panel |
22,410 |
18,033 |
$149K |
| 87631 |
|
1,069 |
1,042 |
$145K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,543 |
2,158 |
$110K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,126 |
617 |
$108K |
| 85027 |
|
25,231 |
19,809 |
$103K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,622 |
2,374 |
$90K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,946 |
759 |
$90K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,157 |
1,080 |
$86K |
| 71046 |
Radiologic examination, chest; 2 views |
5,825 |
5,339 |
$72K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,075 |
1,982 |
$71K |
| 36415 |
Collection of venous blood by venipuncture |
27,275 |
21,368 |
$67K |
| 87581 |
|
1,968 |
1,890 |
$63K |
| 87486 |
|
1,965 |
1,888 |
$63K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
118 |
105 |
$56K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
586 |
511 |
$53K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
884 |
782 |
$47K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,297 |
3,038 |
$43K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
716 |
641 |
$42K |
| 87088 |
|
6,148 |
5,390 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,996 |
2,514 |
$41K |
| 86140 |
|
11,157 |
9,461 |
$41K |
| 81001 |
|
16,278 |
13,744 |
$39K |
| 84703 |
|
5,551 |
4,673 |
$36K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
95 |
88 |
$35K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,147 |
1,087 |
$31K |
| 87507 |
|
100 |
91 |
$31K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
560 |
504 |
$28K |
| 12001 |
|
362 |
343 |
$27K |
| 90870 |
|
197 |
52 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
640 |
602 |
$20K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
640 |
602 |
$20K |
| 84439 |
|
2,755 |
2,548 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,873 |
1,500 |
$20K |
| 84484 |
|
4,402 |
3,307 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,656 |
1,431 |
$19K |
| 83690 |
|
4,143 |
3,602 |
$19K |
| 12011 |
|
216 |
211 |
$18K |
| Q4133 |
Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) |
29 |
12 |
$18K |
| 74018 |
|
1,324 |
1,232 |
$17K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
129 |
114 |
$17K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,010 |
9,908 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
4,035 |
3,508 |
$15K |
| 87040 |
|
1,835 |
1,084 |
$14K |
| 84112 |
|
189 |
169 |
$14K |
| 87081 |
|
2,041 |
1,958 |
$13K |
| 93971 |
|
321 |
286 |
$13K |
| 87077 |
|
2,039 |
1,808 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,412 |
1,967 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
263 |
241 |
$12K |
| 87186 |
|
1,803 |
1,610 |
$12K |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
688 |
437 |
$11K |
| 83880 |
|
811 |
678 |
$11K |
| 97163 |
|
292 |
262 |
$10K |
| 84702 |
|
698 |
576 |
$10K |
| 73130 |
|
579 |
539 |
$10K |
| 73610 |
|
658 |
608 |
$10K |
| 85379 |
|
1,283 |
1,167 |
$9K |
| 80061 |
Lipid panel |
769 |
711 |
$9K |
| 82550 |
|
2,265 |
1,863 |
$9K |
| 87505 |
|
76 |
74 |
$9K |
| 83605 |
|
1,343 |
1,084 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
462 |
236 |
$9K |
| 73630 |
|
637 |
597 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
165 |
156 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
392 |
268 |
$8K |
| 83735 |
|
2,994 |
2,328 |
$8K |
| 82553 |
|
1,385 |
1,126 |
$7K |
| 36000 |
|
877 |
822 |
$7K |
| 99152 |
|
98 |
93 |
$7K |
| 70486 |
|
110 |
104 |
$7K |
| 87660 |
|
334 |
314 |
$6K |
| 72100 |
|
560 |
523 |
$6K |
| 73110 |
|
380 |
355 |
$6K |
| 76801 |
|
129 |
114 |
$6K |
| 76770 |
|
122 |
114 |
$6K |
| 87480 |
|
334 |
314 |
$6K |
| 87510 |
|
334 |
314 |
$6K |
| 99153 |
Mod sedat endo service >5yrs |
57 |
55 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,083 |
1,912 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
143 |
139 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
69 |
66 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
90 |
77 |
$5K |
| 88304 |
|
196 |
181 |
$5K |
| 73030 |
|
461 |
426 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
138 |
124 |
$5K |
| 87070 |
|
753 |
660 |
$5K |
| 73562 |
|
311 |
296 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
60 |
55 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
37 |
36 |
$5K |
| 82248 |
|
1,218 |
1,014 |
$4K |
| 90715 |
|
238 |
228 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,520 |
2,111 |
$4K |
| 72040 |
|
358 |
327 |
$4K |
| 87205 |
|
1,248 |
1,059 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
314 |
296 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,979 |
3,796 |
$4K |
| 85610 |
|
1,661 |
1,278 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
96 |
85 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
579 |
447 |
$3K |
| 85730 |
|
868 |
774 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
106 |
105 |
$3K |
| G0378 |
Hospital observation service, per hour |
803 |
528 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
249 |
123 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,767 |
1,461 |
$3K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
770 |
715 |
$3K |
| 86850 |
|
611 |
503 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,783 |
2,789 |
$3K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
481 |
110 |
$3K |
| 29125 |
|
61 |
58 |
$3K |
| 73090 |
|
188 |
174 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
12 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
689 |
609 |
$2K |
| 85651 |
|
850 |
752 |
$2K |
| 84145 |
|
153 |
135 |
$2K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,543 |
538 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,741 |
2,540 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
314 |
292 |
$2K |
| 87335 |
|
191 |
185 |
$2K |
| 86900 |
|
749 |
635 |
$2K |
| 87493 |
|
79 |
66 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,858 |
5,490 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,287 |
968 |
$2K |
| 76830 |
Ultrasound, transvaginal |
26 |
26 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
15 |
15 |
$2K |
| 86901 |
|
750 |
635 |
$2K |
| 82728 |
|
168 |
153 |
$2K |
| 87045 |
|
191 |
185 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,594 |
1,372 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
72 |
69 |
$1K |
| 87075 |
|
220 |
197 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
43 |
40 |
$1K |
| 59025 |
Fetal non-stress test |
96 |
50 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,905 |
3,205 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
113 |
75 |
$1K |
| 73590 |
|
116 |
105 |
$1K |
| 73140 |
|
74 |
68 |
$1K |
| 82784 |
|
116 |
109 |
$1K |
| 16020 |
|
17 |
14 |
$1K |
| 74021 |
|
81 |
77 |
$1K |
| 88300 |
|
100 |
93 |
$1K |
| 73560 |
|
75 |
74 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
383 |
197 |
$1K |
| 12002 |
|
14 |
13 |
$910.50 |
| 87329 |
|
77 |
75 |
$787.39 |
| 72131 |
|
14 |
13 |
$771.05 |
| 83550 |
|
120 |
111 |
$723.32 |
| J1644 |
Injection, heparin sodium, per 1000 units |
420 |
307 |
$710.19 |
| 80203 |
|
50 |
50 |
$705.08 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,172 |
771 |
$701.39 |
| 73502 |
|
46 |
42 |
$637.59 |
| 83540 |
|
132 |
124 |
$628.61 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,023 |
910 |
$612.14 |
| 83516 |
|
59 |
58 |
$609.27 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
459 |
336 |
$575.94 |
| 74019 |
|
44 |
40 |
$566.38 |
| 89055 |
|
153 |
148 |
$537.49 |
| J2060 |
Injection, lorazepam, 2 mg |
980 |
872 |
$499.65 |
| 73080 |
|
27 |
26 |
$427.34 |
| 82140 |
|
50 |
41 |
$368.37 |
| 97116 |
|
29 |
12 |
$365.92 |
| 87328 |
|
40 |
39 |
$345.18 |
| 84100 |
|
150 |
92 |
$325.10 |
| 82270 |
|
102 |
96 |
$322.19 |
| 71101 |
|
26 |
25 |
$291.84 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
2,120 |
2,032 |
$283.92 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
90 |
89 |
$253.12 |
| 82247 |
|
45 |
28 |
$250.65 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,066 |
803 |
$243.12 |
| 86308 |
|
44 |
43 |
$242.80 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
221 |
138 |
$223.74 |
| J3360 |
Injection, diazepam, up to 5 mg |
66 |
31 |
$207.90 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
569 |
522 |
$205.05 |
| 89051 |
|
53 |
36 |
$189.72 |
| 73552 |
|
13 |
12 |
$184.34 |
| J2704 |
Injection, propofol, 10 mg |
469 |
422 |
$180.73 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
115 |
97 |
$173.20 |
| 82150 |
|
40 |
30 |
$164.73 |
| 97035 |
|
34 |
12 |
$154.06 |
| 84157 |
|
28 |
24 |
$147.67 |
| 96376 |
|
1,637 |
1,351 |
$147.56 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,045 |
3,274 |
$131.55 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
13 |
$123.84 |
| 82607 |
|
14 |
14 |
$117.25 |
| 0100U |
|
630 |
610 |
$109.34 |
| 86038 |
|
12 |
12 |
$108.24 |
| 81002 |
|
37 |
37 |
$95.89 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
126 |
80 |
$92.39 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
852 |
774 |
$92.12 |
| 82570 |
|
24 |
24 |
$92.00 |
| 82009 |
|
30 |
25 |
$89.21 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
122 |
115 |
$83.75 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
13 |
12 |
$78.56 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
140 |
86 |
$76.50 |
| 80069 |
|
18 |
13 |
$67.55 |
| C1769 |
Guide wire |
191 |
174 |
$64.95 |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
779 |
634 |
$39.07 |
| 76937 |
|
18 |
13 |
$34.38 |
| 84156 |
|
12 |
12 |
$24.48 |
| J7510 |
Prednisolone oral, per 5 mg |
40 |
37 |
$12.60 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
68 |
41 |
$2.71 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
13 |
$0.94 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
78 |
78 |
$0.00 |
| A9270 |
Non-covered item or service |
4,112 |
1,868 |
$0.00 |
| 0098U |
|
651 |
628 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
69 |
65 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
17 |
15 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
14 |
12 |
$0.00 |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
537 |
467 |
$0.00 |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
118 |
68 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
12 |
$0.00 |